Rallybio Corporation - Common Stock (RLYB)

RLYB stock results show that Rallybio missed analyst estimates for earnings per share the second quarter of 2024.

Morgan Stanley's bullish outlook highlights the need for strategic trimming of underperforming biotech stocks to sell.

Discover essential insights on biotech stocks to sell in May to navigate market volatility and safeguard your investment portfolio.

RLYB stock results show that Rallybio beat analyst estimates for earnings per share the first quarter of 2024.

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

The weekly Benzinga Stock Whisper Index highlights five stocks that saw increased interest from readers. Here are this week's stocks to watch.

Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83. The S&P 500 also rose, gaining, 0.83% to 5,203.26.

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday.

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session.

U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94. The S&P 500 also rose, gaining, 0.17% to 5,169.21.

Rallybio partners with Johnson & Johnson to develop therapies targeting fetal and neonatal alloimmune thrombocytopenia, receiving $6.6 million investment. Phase 2 study for RLYB212 set for 2024.

Hub Cyber Security stock is falling on Thursday after the company noted an investor sold a large stake of its HUBC shares.

Aptevo Therapeutics stock is falling on Thursday after the company priced a public offering for 3.4 million shares of APVO.

Rent the Runway stock is on the rise Thursday as investors in the company celebrate strong revenue in its most recent earnings report.

Rallybio stock is rocketing higher on Thursday with heavy trading of RLYB shares after announcing a collaboration with Johnson & Johnson.

We're starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning!